Combined with our research results, we speculate that the up-regulation of BID may regulate the internal energy metabolism of ccRCC by hindering the insulin signaling pathway, thereby increasing the demand for tumor biosynthesis and leading to tumor progression. This evidence concerns the gene BID and nonpapillary renal cell carcinoma.